Evidence map›Paper›PMID 26553060›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2016

Myocardial denervation coincides with scar heterogeneity in ischemic cardiomyopathy: A PET and CMR study.

Stefan de Haan, Mischa T Rijnierse, Hendrik J Harms, Hein J Verberne, Adriaan A Lammertsma, Marc C Huisman, Albert D Windhorst, Albert C van Rossum, Cornelis P Allaart, Paul Knaapen

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Multiparametric Imaging of Organ System Interfaces.Circulation. Cardiovascular imaging · 2017
    Review
  5. A rose by any other name.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Stefan de HaanDepartment of Cardiology and Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands.
Mischa T RijnierseDepartment of Cardiology and Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands.
Hendrik J HarmsDepartment of Nuclear Medicine & PET Research, VU University Medical Center, Amsterdam, The Netherlands.
Hein J VerberneDepartment of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Adriaan A LammertsmaDepartment of Nuclear Medicine & PET Research, VU University Medical Center, Amsterdam, The Netherlands.
Marc C HuismanDepartment of Nuclear Medicine & PET Research, VU University Medical Center, Amsterdam, The Netherlands.
Albert D WindhorstDepartment of Nuclear Medicine & PET Research, VU University Medical Center, Amsterdam, The Netherlands.
Albert C van RossumDepartment of Cardiology and Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands.
Cornelis P AllaartDepartment of Cardiology and Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands.
Paul KnaapenDepartment of Cardiology and Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands. p.knaapen@vumc.nl.
Amsterdam UMC Location VUmc · NLAcademic Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMismatch between myocardial innervation and perfusion assessed with positron emission tomography (PET) is a potential risk marker for ventricular arrhythmias in patients with ischemic cardiomyopathy. This mismatch zone originates from residual viable myocardium that has sustained ischemic nerve injury. Heterogenic scar size assessed with late gadolinium-enhanced (LGE) cardiac magnetic resonance imaging (CMR) is also a risk marker of ventricular arrhythmias. These two imaging parameters may represent identical morphological tissue features. The current study explored the relation between innervation-perfusion mismatch and heterogenic scar size.

methodsTwenty-eight patients (26 males, age 67 ± 8 years) with ischemic cardiomyopathy and a left ventricular ejection fraction below 35%, eligible for ICD implantation were included. All patients underwent both [

resultsPerfusion defect size was 16.6 ± 9.9% and innervation defect size was 33.7 ± 10.8%, which resulted in an innervation-perfusion mismatch of 17.6 ± 8.9%. Total scar size, scar core size, and heterogenic scar size were 21.2 ± 8.6%, 14.7 ± 6.6%, and 6.5 ± 2.9%, respectively. No relation between scar core size and perfusion deficit size was observed (r = 0.18, P = .36). Total scar size was correlated with the innervation defect size (r = 0.52, P = .004) and the heterogenic scar zone displayed a significant correlation with the innervation-perfusion mismatch area (r = 0.67, P < .001).

conclusionsDenerved residual viable myocardium in ischemic cardiomyopathy as observed with innervation-perfusion PET is related to the heterogenic scar zone as assessed with LGE CMR.

Indexed as

AgedCardiomyopathiesCicatrixDenervationFemaleHeartHumansMagnetic Resonance Imaging, CineMaleMyocardial IschemiaPositron-Emission TomographyReproducibility of ResultsSensitivity and Specificitydelayed contrast enhancementMRImyocardial innervationPET

Identifiers

PMID26553060
OpenAlexW2168854895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.